Bovis Homes Group Stock Rating Reaffirmed by Deutsche Bank (BVS)

Bovis Homes Group (LON: BVS)‘s stock had its “buy” rating restated by equities research analysts at Deutsche Bank in a research note issued to investors on Tuesday, AnalystRatings.Net reports. They currently have a GBX 878 ($13.79) target price on the stock, up from their previous target price of GBX 863 ($13.55). Deutsche Bank’s price objective suggests a potential upside of 14.03% from the stock’s previous close.

Shares of Bovis Homes Group (LON: BVS) opened at 770.50 on Tuesday. Bovis Homes Group has a 52 week low of GBX 426.50 and a 52 week high of GBX 783.63. The stock’s 50-day moving average is currently GBX 501.4. The company’s market cap is £1.032 billion.

BVS has been the subject of a number of other recent research reports. Analysts at Jefferies Group reiterated a “buy” rating on shares of Bovis Homes Group in a research note to investors on Monday, June 10th. They now have a GBX 897 ($14.09) price target on the stock. Separately, analysts at HSBC reiterated an “overweight” rating on shares of Bovis Homes Group in a research note to investors on Friday, June 7th. They now have a GBX 950 ($14.92) price target on the stock. Finally, analysts at Citigroup reiterated a “neutral” rating on shares of Bovis Homes Group in a research note to investors on Wednesday, June 5th. They now have a GBX 820 ($12.88) price target on the stock, up previously from GBX 710 ($11.15).

Seven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of GBX 793.46 ($12.46).

Bovis Homes Group PLC is a builder of traditional homes in England and Wales. The Company’s business involves the designing, building and selling of new homes for both private and public sector customers.

Latest News

UnitedHealth Group  Price Target Increased to $300.00 by Analysts at BMO Capital Markets
UnitedHealth Group Price Target Increased to $300.00 by Analysts at BMO Capital Markets
VICI Properties  Lifted to “Buy” at Zacks Investment Research
VICI Properties Lifted to “Buy” at Zacks Investment Research
TJX Companies  Stock Rating Upgraded by ValuEngine
TJX Companies Stock Rating Upgraded by ValuEngine
TransDigm Group  Upgraded by ValuEngine to “Buy”
TransDigm Group Upgraded by ValuEngine to “Buy”
Castlight Health Inc  Given Average Recommendation of “Hold” by Analysts
Castlight Health Inc Given Average Recommendation of “Hold” by Analysts
Relx  Earning Favorable News Coverage, Report Shows
Relx Earning Favorable News Coverage, Report Shows


© 2006-2018 Ticker Report. Google+.